CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial of Dasatinib in Advanced Sarcomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00464620
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:05.405384+00:00
Published At: 2018-11-23T00:00:00+00:00
Record Updated At: 2018-11-23
Results Posted At: 2018-11-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rhabdomyosarcoma", "Malignant Peripheral Nerve Sheath Tumors", "Chondrosarcoma", "Sarcoma, Ewing\u0027s", "Sarcoma, Alveolar Soft Part", "Chordoma", "Epithelioid Sarcoma", "Giant Cell Tumor of Bone", "Hemangiopericytoma", "Gastrointestinal Stromal Tumor (GIST)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-11-23"
protocolSection.identificationModule.nctId: "NCT00464620"
protocolSection.identificationModule.officialTitle: "A Phase II Trial of Dasatinib in Advanced Sarcomas"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-11-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.